• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

255.4500 USD 3.8900 1.50%

As of 20:10:00 ET on 07/24/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 260.0100 High - Low: 260.0100 - 254.6900 Primary Exchange: NASDAQ GM
Volume: 1,717,231 52-Week Range: 187.0500 - 275.4000 Beta vs XNBI: 1.0036

ETF Chart for IBB

No chart data available.
  • IBB:US 255.6200
  • 1D
  • 1M
  • 1Y
259.3400
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-07-24) 255.4800
Assets (M) (on 2014-07-23) 5,413.2060
Shares out (M) 20.50
Market Cap (M) 5,236.73
% Premium -0.01
Average 52-Week % Premium 0.0004
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.15%

Performance for IBB

1-Month +0.14% 1-Year +32.55%
3-Month +11.42% 3-Year +32.97%
Year To Date +12.68% 5-Year +27.06%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 07/23/2014
Name Position Value % of Total
Celgene Corp 5,112,209 455,600,066 8.602%
Gilead Sciences Inc 4,816,725 435,142,937 8.215%
Biogen Idec Inc 1,224,809 413,495,518 7.807%
Amgen Inc 3,372,426 411,469,696 7.768%
Alexion Pharmaceuticals Inc 2,149,936 372,110,923 7.025%
Vertex Pharmaceuticals Inc 2,706,668 265,632,398 5.015%
Illumina Inc 1,235,915 223,255,686 4.215%
Mylan Inc/PA 3,924,230 205,394,198 3.878%
Regeneron Pharmaceuticals Inc 637,164 197,692,874 3.732%
Endo International PLC 1,782,643 125,266,324 2.365%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil